24/7 Market News – Allena Pharmaceuticals Inc. (NASDAQ: ALNA) higher on cancellation of its recent dilutive Common Shares Sales Agreement

(24/7 MARKET NEWS) Allena Pharmaceuticals Inc. (NASDAQ: ALNA) popped in yesterday’s afterhours session to over $0.23 per share, after announcing that it was taking its B. Riley Securities funding agreement off the table.

It closed yesterday’s regular session at $0.119, down $0.0067 (-5.3302%), but is holding most of the afterhours gains at $0.21, up $0.09 (+76.22%), on 12,962,427 premarket shares traded.

24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist